ArticleCureus2025
Critical Limb Ischaemia in a Patient With Subcutaneous Nodules: Clues to a Hidden Systemic Disease.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatomyositis most commonly presents with characteristic rash or proximal muscle weakness; however, specific autoantibody subsets can produce markedly atypical phenotypes. Anti-NXP2 dermatomyositis is clinically significant for its strong association with malignancy, extensive calcinosis, and presentations that may be amyopathic or minimally symptomatic. We report a rare case of anti-NXP2-positive dermatomyositis manifesting without classical cutaneous or muscular features, instead presenting with acute limb ischemia and long-standing subcutaneous nodules. Amyopathic anti-NXP2 disease is uncommon in adults, accounting for a small minority of dermatomyositis cases, making this presentation particularly unusual. Imaging demonstrated diffuse subcutaneous and intramuscular calcifications with large-vessel disease, while serologic testing confirmed anti-NXP2 antibodies. Following revascularization and multidisciplinary evaluation, limb perfusion and wound healing improved for this case. Amyopathic presentations of anti-NXP2 dermatomyositis are rare, reported in only a small subset of patients, highlighting the atypical nature of this case. This case underscores the need to consider autoimmune myositis in patients presenting with calcinosis cutis and ischemic changes, as recognition of anti-NXP2 dermatomyositis is essential for early diagnosis, multidisciplinary management, guidance of oncologic surveillance, and prevention of irreversible vascular outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.